NEUROLOGIC DISORDERS

95
NEUROLOGIC DISORDERS Myasthenia Gravis Parkinsons Disease Multiple Sclerosis Amyotrophic Lateral Schlerosis Spinal Cord Injury Intervertebral Disc Herniation Cranial Nerve Problems 2009

description

NEUROLOGIC DISORDERS. Myasthenia Gravis Parkinsons Disease Multiple Sclerosis Amyotrophic Lateral Schlerosis Spinal Cord Injury Intervertebral Disc Herniation Cranial Nerve Problems 2009. Myasthenia Gravis. DEFINITION. problem in neurotransmission - PowerPoint PPT Presentation

Transcript of NEUROLOGIC DISORDERS

Page 1: NEUROLOGIC DISORDERS

NEUROLOGIC DISORDERS

Myasthenia GravisParkinsons DiseaseMultiple Sclerosis

Amyotrophic Lateral SchlerosisSpinal Cord Injury

Intervertebral Disc HerniationCranial Nerve Problems

2009

Page 2: NEUROLOGIC DISORDERS

Myasthenia Gravis

Page 3: NEUROLOGIC DISORDERS

DEFINITION

• problem in neurotransmission• severe fatigue of voluntary muscles• defect of acetylcholine receptor sites

at the myoneuronal junction• theories indicate autoimmune problem• Remissions/exacerbations• Progressive proximal muscle weakness

improving with rest

Page 4: NEUROLOGIC DISORDERS

CLINICAL MANIFESTATIONS

• Patients indicate abnormal fatigue of the voluntary muscles of the eye, the respiratory tract and the limb muscles

• Also have difficulty with speech and swallowing• End up choking with meals• Ptosis, diplopia, dysphagia• MOST ADVANCED: all muscles weakened: no

respiratory function, no bladder and bowel function

Page 5: NEUROLOGIC DISORDERS

DIAGNOSTIC TESTS

• Tensilon test: – give patient a short acting anticholinesterase

(Tensilon or edrophonium chloride) that enhances neurotransmission and results in abrupt, but short term improvement of symptoms• Atropine : antidote for Tensilon

• EMG: electromyography:

Page 6: NEUROLOGIC DISORDERS

LABORATORY ASSESSMENT

• THYROID FUNCTION STUDIES DONE: thyrotoxicosis seen with MG

• Serum protein electrophoresis: for immunologic disorders

• Acetylcholine receptor antibodies (AChR): important diagnositic criterion 80-90% of clients with MG have elevated AChR

• Often have thymoma or hyperplasia of thymus gland

Page 7: NEUROLOGIC DISORDERS

DRUG THERAPYAnticholinesterase medications:– Pyridostigmine bromide (Mestinon),

neostigmine bromide (Prostigmin) Increases acetylcholine at the neuromuscular junction

– Dosage regulated based on improved strength and less fatigue

– MUST BE GIVEN ON TIME to keep stable blood levels• RESULT: pt weakness worse

Page 8: NEUROLOGIC DISORDERS

DRUGS TO AVOID: increase weakness

• Magnesium• Morphine• Curare• Quinine• Quinidine• Procainamide• Hypnotics• sedatives

• Antibiotics: • Neomycin• Kanamycin• Polymyxin B• tetracyclines

Page 9: NEUROLOGIC DISORDERS

DRUG THERAPY

• Corticosteroids used to control and improve symtoms:

• prednisone(Deltasone, Winpred)– As steroids increased anticholinesterase dosage

decreased

• Cytotoxic medications used: – why they work unknown

Page 10: NEUROLOGIC DISORDERS

TREATMENT

• PLASMAPHERESIS: plasma exchange– Used to treat exacerbations– HOW IS THIS DONE: Blood cells and antibody

containing plasma separated out then the cells and a plasma substitute reinfused

– Improves symptoms in 75% of patients

Page 11: NEUROLOGIC DISORDERS

TREATMENT CONTINUED

• IV immune globulin (IVIG) • Works as well as plasmapheresis during

exacerbations

Page 12: NEUROLOGIC DISORDERS

Summary of therapies

• Not a cure• Does not stop the production of acetylcholine

receptor antibiodies

Page 13: NEUROLOGIC DISORDERS

SURGICAL TREATMENT

• Thymectomy continues to be associated with improvement in 50-92%% of patients

• RESULT: – produces antigen specific immunosuppression– Results in clinical improvement– Decreases need for medication– Takes a year for benefit to be seen because of the long life

of circulating T cells

Page 14: NEUROLOGIC DISORDERS

MYASTHENIC CRISIS

• SEEN WITH UNDERMEDICATION WITH CHOLINESTERASE INHIBITORS

• Severe generalized weakness and respiratory failure• Seen after stress (URI, infection, medication change,

surgery, obstetrical delivery, high environmental temperature)

• Patient needs ventilatory support• Patient will need help with all ADL• Suctioning, chest PT

Page 15: NEUROLOGIC DISORDERS

CHOLINERGIC CRISIS

• RESULT OF OVERMEDICATION WITH ANTICHOLINESTERASE DRUGS

• Can mimic symptoms of myasthenic crisis• Differentiated via Tensilon test• Pt with Myasthenic Crisis will show immediate

improvement following Tensilon administration• Pt with Anticholinergic Crisis will show no

improvement and may get worse

Page 16: NEUROLOGIC DISORDERS

TREATMENT OF CHOLINERGIC CRISIS

• STOP ALL ANTICHOLINESTRASE MEDICATIONS• Give Atropine sulfate given IV• SE: secretions thickened

Page 17: NEUROLOGIC DISORDERS

NURSING DIAGNOSIS

Page 18: NEUROLOGIC DISORDERS

THYMECTOMY:

• REMOVAL OF THYMUS GLAND DONE EARLY IN DISEASE

• May take several years for remission to occur if it occurs at all

• Review p 1017 Iggy

Page 19: NEUROLOGIC DISORDERS

NURSING CARE

• Most pts seen on outpatient basis• Teaching: – use of medications– S&S of myasthenic crisis and choinergic crisis– How to conserve energy– Ways to avoid aspiration– Have suction at home– Gastrostomy feeding instruction– Avoid factors that increase crisis– Eye care

Page 20: NEUROLOGIC DISORDERS

PARKINSONS DISEASE

Page 21: NEUROLOGIC DISORDERS

DEFINED

Presence of motor dysfunction with 4 cardinal symptoms

• resting tremor• akinesia (slowness of body movement)• rigidity• Postural instabilityNO PREVENTION, NO CUREAGE RANGE: 40-70, PEAK 60Michael J. Fox dx at age 30

Page 22: NEUROLOGIC DISORDERS

PATHOPHYSIOLOGY

Reduced amount of dopamine• Result: inhibition effect lost• Excitatory effect predominantReduced norepinephrine in sympathetic NS of

the heart:• Orthostatic hypotension

Page 23: NEUROLOGIC DISORDERS

ASSESSMENT:

• Initially: one limb involved with mild weakness and arm and hand trembling

• Progresses to both limbs involved, slow shuffling gait• Continues to worsen: gait disturbances(slow

shuffling, short hesitant steps, propulsive gait• Severe involvement: akinesia, rigidity, CANNOT GET

OOD

Page 24: NEUROLOGIC DISORDERS

FURTHER ASSESSMENT:

• Rigidity of facial muscles: • masklike facies• Drooling• Dysphagia• Dysarthria: Rapid slurred speech• Echolalia: repetition

Page 25: NEUROLOGIC DISORDERS

ASSESSMENT CONTINUED

• PSYCHOSOCIAL• Emotionally labile• Delayed reaction time

Page 26: NEUROLOGIC DISORDERS

DRUGS• ANTIPARKINSON AGENT: monoamine oxidase

type b inhibitor: selegiline (Eldepryl, Carbex, Novo-Selegiline): used to protect the neurons, successful in reducing the use of Levodopa until later

• Catechol O-methyltransferase (COMT) inhibitors: – Tolcapone (Tasmar)– Entacapone (Comtan)Block breakdown of levodopa in body so more can go

to brain and convert to dopamine

Page 27: NEUROLOGIC DISORDERS

DRUGS

• DOPAMINE AGONISTS: providing dopamine that is missing– Levodopa (Dopar, L-dopa) and– carbidopa (Sinemet):

ANTIPARKINSON AGENT/ANTIVIRAL:• amantadine (Symmetrel): potentiates

action of dopamine in CNS, treats tremor; also treats symptoms of “wearing off”

Page 28: NEUROLOGIC DISORDERS

TREATMENT

• Meds may need drug holiday - effectiveness after used for long time; admit to hospital to try other drugs

• p693 FOR SURGICAL tx• Stereotactic Pallidotomy/Thalamotomy

Deep brain stimulationfetal Tissue transplant

Page 29: NEUROLOGIC DISORDERS

NURSING DIAGNOSIS

• Self-care deficit related to slowness of movement and muscle rigidity

• Risk for injury related to postural instability and muscular rigidity

• Impaired verbal communication related to slowness of movement

• Altered nutrition related to poor muscle control

Page 30: NEUROLOGIC DISORDERS

NURSING DIAGNOSIS CONTINUED

• Knowledge deficit related to complexity of and fluctuations in treatment regimen

• Ineffective coping relate to progressive nature of illness

Page 31: NEUROLOGIC DISORDERS

IMPLEMENTATION

• Establish routine for personal care• Safety in bathing, transferring, walking• AROM, PROM• Encourage pt to take a deep breath before

initiating a conversation, using gestures• Rigidity of facial expression hides pts true

feelings

Page 32: NEUROLOGIC DISORDERS

IMPLEMENTATION

• Meals thickened liquids, semisolids• Eat sitting up• Suction • Daily wgts• Increase fluids/day for constipation • Drug flowsheet to document response to

medications• Keep patient active as long as possible

Page 33: NEUROLOGIC DISORDERS

MULTIPLE SCLEROSIS

AUTOIMMUNE DISORDER

Page 34: NEUROLOGIC DISORDERS

DEFINED

• Demyelinating disease affecting nerve fibers of the brain and spinal cord

• CAUSE unknown. Thought to be an autoimmune problem with a viral trigger

• Lesions scattered through the white matter of the brain around the ventricles; some in grey matter

• Inflammatory response triggers phagocytosis with myelin as the target

Page 35: NEUROLOGIC DISORDERS

OLDER DRUG THERAPY

• The most widely accepted drug treatment is corticosteroids :

• Methylprednisolone(Solumedrol)• Given IV followed by oral prednisone– Steroids decrease the inflammatory

response, decrease the edema, improvement of symptoms

• Cyclophosphamide (Cytoxan) used for chronic progressive disease to produce temporary remission from 1-3 years

Page 36: NEUROLOGIC DISORDERS

DEFINITION CONTINUED

• Edema around lesions• Eventually a hard plaque forms• Characterized by exacerbations and remissions• Progressive from benign with few symptoms to

chronic with complete paralysis. • 70% of pts lead active productive lives with long

periods of remission

Page 37: NEUROLOGIC DISORDERS

DIAGNOSIS

• lumbar puncture: CSF shows increase protein, lymphocytes, IgG, presence of oligoclonal bands and increased myelin basic protein

• EMG: prolonged impulse conduction• MRI: demonstrates white matter lesions

(plaques) of brain, brainstem and spinal cord

Page 38: NEUROLOGIC DISORDERS

NEW DRUG THERAPYBIOLOGICAL RESPONSE MODIFIERS:

recommended to use one of these three: • Interferon beta -1a (Avonex) - weekly IM• Interferon beta-1b recombinant (Betaseron) -

every other day SQ• PURPOSE AND SIDE EFFECTS OF BOTH– Slows physical disability, decreases physical

worsening of disease– Major SE: suicidal tendency, depression

• Glatiramer acetate (formerly Copolymer I) (Copaxone) - every other day SQ

Page 39: NEUROLOGIC DISORDERS

SYMPTOMS

• Blurred vision• Double vision• Dysphagia• Facial weakness• Numbness• Pain• Weakness

Page 40: NEUROLOGIC DISORDERS

Symptoms Continued

• paralysis• abnormal gait• tremor• vertigo• fecal and urinary incontinence• decreased short term memory• word finding trouble

Page 41: NEUROLOGIC DISORDERS

Symptoms Continued

• decreased concentration• mood alteration• decreased libido for women• ejaculatory dysfunction for men• overwhelming weakness

Page 42: NEUROLOGIC DISORDERS

DRUGS• Baclofen (Lioresal), Diazepam (Valium), Dantrolene

sodium(Dantrium) - for spasticity• Carbamazepine (Tegretol), tricyclic antidepressants

(amitriptyline),: paresthesia• propranolol (Inderal), clonazepam (Klonopin) – used

for cerebral ataxia• Amantadine hydrochloride (Symmetrel): fatigue• oxybutynin chloride (Ditropan), propantheline

bromide (ProBanthine) - decreased urinary urgency, incontinence

• Bulk additives (Metamucil) - constipation• Colace - improved bowel control• Dulcolax – stimulant• Tizanidine (Sanaflex) antispasmodic for pain

Page 43: NEUROLOGIC DISORDERS

NURSING INTERVENTIONS

• Self-care deficit: balance assistance with independence; promote own routine

• Urinary retention/incontinence: intermittent catherization, Texas catheter for men

• Bowel incontinence: regular routine, high fiber diet, and fluids

• Impaired skin integrity related to immobility: skin assessment

Page 44: NEUROLOGIC DISORDERS

NURSING INTERVENTION

• Fatigue related to disease process: pace self

Page 45: NEUROLOGIC DISORDERS

AMYOTROPHIC LATERAL SCLEROSIS

Lou Gerhig’s Disease

Page 46: NEUROLOGIC DISORDERS

Amyotrophic Lateral Sclerosis or Lou Gehrig’s disease

• Progresive degenerative disease involving the motor system (motor neurons)

• Sensory and autonomic systems not involved• No mental status changes

Page 47: NEUROLOGIC DISORDERS

Cause

• Excess of glutamate: chemical responsible for relaying messages between the motor neurons

• As the motor neurons die the muscle cells they supply undergo atrophic changes leading to paralysis

Page 48: NEUROLOGIC DISORDERS

PROGRESSION OF DISEASE

• Muscle weakness and atrophy develop leading to flaccid quadriplegia

• Eventually respiratory muscles become affected leading to respiratory compromise, pneumonia and death

• No known cure, treatment symptomatic

Page 49: NEUROLOGIC DISORDERS

WHAT DO YOU SEE?

• FATIGUE• Fatigue while talking• Muscle

weakness/atrophy• Tongue atrophy• Dysphagia (difficulty

swallowing)• Weakness hands and

arms

• Fasciculations (twitching) of face

• Nasal quality of speech

• Dysarthria (difficulty speaking)

Page 50: NEUROLOGIC DISORDERS

CARE

• Focus on symptoms• Monitor respiratory status• Prepare to initiate respiratory support• Assess complications of immobility

Page 51: NEUROLOGIC DISORDERS

SPINAL CORD INJURY

Page 52: NEUROLOGIC DISORDERS

DEFINED

• Fractures, contusions, or compression of the vertebral column with damage to the spinal cord

• The injury affects motor and sensory function at the level of injury and below

SPINAL CORD INJURIES are classified as complete or incomplete

• Complete: total cord transection• Incomplete: partial transection

Page 53: NEUROLOGIC DISORDERS

FOUR TYPES OF INJURIES OCCUR

• HYPERFLEXION: compresses vertebral bodies and disrupts ligaments and discs

• HYPEREXTENSION: disrupts ligaments and causes vertebral fractures

• AXIAL LOADING: application of excessive vertical force and may cause compression fractures

• EXCESSIVE ROTATION: tears ligaments and fractures articular surfaces and causes compression fractures

Page 54: NEUROLOGIC DISORDERS

SPINAL SHOCK• With cord damage spinal shock occurs and areflexia

(temporary loss of reflex functioning)• Loss of motor sensory, and autonomic activity below

the level of injury • Then leads to decrease in blood pressure and

bradycardia• The parts of body below the level of the cord injury

are paralyzed without sensation or diaphoresis• Lasts days or months after injury

Page 55: NEUROLOGIC DISORDERS

DEFINITIONS OF PARALYSIS

• PARAPLEGIA: paralysis of the lower portion of the body; occurs when the injury level is in the thoracic spine or lower

• Tetraplegia: formerly quadriplegia is paralysis of the arms, trunk, legs and pelvic portion; occurs when the level of injury is in the cervical spine

Page 56: NEUROLOGIC DISORDERS

EMERGENCY TREATMENT

• DO NOT MOVE THE CLIENT until adequate personnel and equipment are available

• Keep the neck aligned• Immobilize the head and neck• Maintain a patent airway (with cervical injury

edema may cause respiratory difficulty

Page 57: NEUROLOGIC DISORDERS

ADMINISTER DRUGS• High dose corticosteroids: – reduces disability in 8hrs of injury

• Osmotic diuretics: mannitol (Osmitrol) – Decreases edema around spinal cord

• Muscle relaxants: baclofen (Lioresal)– Reduces spasticity

• Dextran– prevents BP; improves capillary blood flow

• dopamine hydrochloride (Intropin) and isoproterenol (Isuprel): inotropic and sympathomimetic agents for severe hypotension

Page 58: NEUROLOGIC DISORDERS

IMMOBILIZATION

• Goal: reduce dislocations and stabilize cervical vertebral column

HOW? • Skeletal traction (skeletal tongs such as Gardner–

Wells tongs or Crutchfield tongs)• Halo tractionCARE: weights hang freely, never remove weights,

clean tongs, assess for infection

Page 59: NEUROLOGIC DISORDERS

SURGERY

• Surgical immobilization via anterior and posterior decompression and fusion with bone grafts

• DECOMPRESSION WITH LAMINECTOMY: remove bony fragments that cause compression, remove foreign body causing compression

• FUSION: anterior, posterior or anterior/posterior using Harrington rods

Page 60: NEUROLOGIC DISORDERS

IMMOBILIZATION AFTER SURGERY

• SOMI JACKET• CTLSO

Page 61: NEUROLOGIC DISORDERS

AUTONOMIC DYSREFLEXIA

DEFINED:• Exaggerated sympathetic response that occurs in

clients with T6 injuries or higher• Response seen after spinal shock occurs when stimuli

cannot ascend the cord• Stimulus (urge to void) triggers massive

vasoconstriction below the injury, vasodilation above the injury, and bradycardia

Page 62: NEUROLOGIC DISORDERS

CAUSES OF AUTONOMIC DYSREFLEXIA

MOST COMMON: overdistended bladder• Bowel impaction, rectal exam• UTI, bladder spasms, renal calculi• Pressure sores, ingrown toenail• Burns, blows to body• Tight clothing, tight cast

Page 63: NEUROLOGIC DISORDERS

S & S AUTONOMIC DYSREFLEXIA

• Sudden pounding severe HA• Severe hypertension, bradycardia• Flushing, sweating above the level of injury• Piloerection (goose bumps)• Nasal congestion• Apprehension• Blotching above the level of injury

Page 64: NEUROLOGIC DISORDERS

TX OF AUTONOMIC DYSREFLEXIA

SERIOUS MEDICAL EMERGENCY! ACT QUICKLY! DO NOT WAIT!

• Identify/remove the stimulus• Reduce the BP• Administer drugs• Teach pt how to deal with it

Page 65: NEUROLOGIC DISORDERS

TX OF AUTONOMIC DYSREFLEXIA

• REQUEST HELP• HOB up!• Check BP q 5 minutes• Do straight cath of bladder; eval bowel• Remove tight clothing, check orthotics• Check skin, toenails• Report to MD if BP still won’t decrease

Page 66: NEUROLOGIC DISORDERS

DRUGS FOR AUTONOMIC DYSREFLEXIA

ACUTE PHASE: • Nitropaste (vasodilator)• Arfonad IV (ganglionic blocker to lower BP fast)• Apresoline IV (relaxes arterolar smooth muscle)• Low spinal anesthetic at L4 if no results with drugsPREVENTION: antihypertensives

Page 67: NEUROLOGIC DISORDERS

BLADDER PROBLEMS

• INCONTINENCE• UTI• URINARY CALCULI• BLADDER SPASMS

Page 68: NEUROLOGIC DISORDERS

SPASTIC BLADDER

• Clients have Injury above the sacrum• End up with upper motor neuron spastic bladder• May be able to stimulate voiding by– Stroking inner thigh– Pullin on pubic hair– Pouring warm water over perineum– Tapping bladder to stimulate detrusor muscle– Taking bethanechol chloride (Urecholine); cholinergic

agent which helps contraction of detrusor mucle: take 1 hour before trying to void

Page 69: NEUROLOGIC DISORDERS

FLACCID BLADDER

• Clients with lumbosacral injury• Have lower motor neuron flaccid bladder• Able to empty bladder by:– Tightening abdominal muscles– Intermittent cath two or three times daily

Page 70: NEUROLOGIC DISORDERS

TREATMENT OF THE URINARY PROBLEMS

• Intermittent catherization :Clean cath• Prevents incontinence, dysreflexia, UTI,

calculiCAUTION: never drain more than 700cc/ leads

to hypovolemic shock• increase fluid, water, high acidity fluids, no

alcohol, low soda (hi salt), low milk, avoid alkaline fluids

Page 71: NEUROLOGIC DISORDERS

DRUGS FOR ELIMINATION PROBLEMS

• oxybutynin (Ditropan) : decreases urinary incontinence• propantheline(Pro Banthine): reduces bladder spasms• ascorbic acid (Vitamin C): increases urine acidity;

prevents UTI; works with Mandelamine• methenamine (Mandelamine): urinary tract antisepticto

prevent UTI; do not combine with carbonic annhydrase inhibitors, sulfa drugs or diuretics

• Imipramine (Tofranil) antidepressant used to tx urinary incontinence (side effect: urinary retention))

Page 72: NEUROLOGIC DISORDERS

BOWEL ELIMINATION PROBLEMS

ConstipationLoss of bowel control

TREATMENT: Bowel Program• Combination of stool softeners, bulk formers,

laxatives• High fiber diet, high fluids

Page 73: NEUROLOGIC DISORDERS

Bowel Program

• Consitent time• High fluid intake• High fiber diet

Page 74: NEUROLOGIC DISORDERS

DRUGS FOR BOWEL ELIMINATION PROBLEMS

• docusate sodium(Colace): stool softener• senna (Senekot): laxative• bisacodyl (Dulcolax): laxative• dibucaine (Nupercainal): ointment anesthetic

used prior to beginning bowel program to prevent autonomic dysreflexia

• psyllium (Metamucil): bulk forming agent

Page 75: NEUROLOGIC DISORDERS

OTHER PROBLEMS

Mostly related to immobility• RESPIRATORY: pneumonia, PE• MOBILITY: contractures, spasticity, decubitus, burns,

bruises, fractures, osteoporosis• CIRCULATORY: DVT/edema, postural hypotension, GI

bleed• SEXUAL: males have decreased fertility, females can

bear children

Page 76: NEUROLOGIC DISORDERS

INTERVERTEBRAL DISC HERNIATION

Page 77: NEUROLOGIC DISORDERS

DEFINED• Disorder involving impingement of a vertebral disk’s

nucleus pulposus on spinal nerve roots causing pain and possible neuromuscular deficit

TREATMENT conservative:• with muscle relaxants: cyclobenzaprine

hydrochloride (Flexeril) • Nonsteroidal anti-inflammatory drugs (NSAIDS):

naproxen (Naprosyn)• Epidural or local steroid injection• Rest, heat, muscle strengthening exercises, pelvic

tilts, straight leg raises

Page 78: NEUROLOGIC DISORDERS

MINIMALLY INVASIVE SURGERY(see page 980 of Iggy)

ADVANTAGE: ambulatory procedure or shortened hospital stay with less spinal cord complications

• Percutaneous lumbar diskectomy• Microdiskectomy• Laser-assisted laparoscopic lumbar

diskectomy

Page 79: NEUROLOGIC DISORDERS

SURGERY see p980 of Iggy

• Diskectomy: spinal nerve is lifted to remove the offending portion of the disk

• Laminectomy: removal of 1 or more vertebral lamina and the herniated nucleus pulposus

• Spinal fusion (arthrodesis): to stabilize area using chips of bone from iliac crest grafted to vertebrae

Page 80: NEUROLOGIC DISORDERS

SURGICAL MANAGEMENTLAMINECTOMY: surgical incision of the lamina to relieve

symptoms related to herniated intervertebral discPOST OP CARE: • Neurological and neurovascular assessment, assessment of

bowel and bladder function• Assess for c/o severe HA or leakage of CSF• Log roll, proper alignment• Bedrest 24-48 hours; rise as a unit when getting OOB first

time• Paresthesias may not be relieved immediately

Page 81: NEUROLOGIC DISORDERS

AMPUTATION

Page 82: NEUROLOGIC DISORDERS

COMMON AMPUTATION SITES

Page 83: NEUROLOGIC DISORDERS

TYPES OF SURGERY FEMUR PATELLA

• femur patella

Page 84: NEUROLOGIC DISORDERS

TYPES OF PROSTHESES• TOTAL CONTACT RIGID DRESSING: applied in OR to

protect stump swelling

• PERMANENT LEG PROSTHESIS: rigid dressing that connects to an adjustable pylon and foot ankle assembly to permit walking; need 3-4 of these, stump shrinks with healing

• SOFT DRESSING: when frequent inspection needed; may have drainage device

Page 85: NEUROLOGIC DISORDERS

COMPLICATIONS

• Bleeding• Infection• Skin breakdown• PHANTOM LIMB PAIN• FLEXION CONTRACTURES

Page 86: NEUROLOGIC DISORDERS

NURSING CARE

1. Proper positioning to minimize contractures

2. Watch use of pillow under stump

3. Lie prone4. Phantom limb pain5. Monitor for excessive

bleeding6. Prevent stump edema7. Assess for infection

8. Assess for hematoma formation

9. Teach stump care10. Teach use of prosthesis11. Provide referral to

National Amputee Foundation and Amputee Shoe and Glove Exchange

Page 87: NEUROLOGIC DISORDERS

CRANIAL NERVE DISORDERS

Trigeminal NeuralgiaBells Palsy

Guillan-Barre Syndrome

Page 88: NEUROLOGIC DISORDERS

Trigeminal Neuralgia• DEFINED: chronic disease of the trigeminal nerve causing

severe facial pain unknown cause• Pain occurs briefly, intense skin surface pain 100 times/day or

a few times a year• Starts peripherally and advances centrally• Some trigger zones initiate pain• TREATED WITH: seizure drugs: carbamazepine (Tegretol);

phenytoin (Dilantin)• SURGICAL TREATMENT: removal of blood vessel from

posterior trigeminal root or severing nerve root• NURSING DX: risk for imbalanced nutrition; pain

Page 89: NEUROLOGIC DISORDERS

Bell’s Palsy• DEFINED: unilateral paralysis of facial muscles; unknown

cause; inflammation of the nerve and viral cause suggested; recover within few weeks/months, some have permanent paralysis

• SEE: one sided paralysis of facial muscles and upper eyelid, loss of taste on affected side, increased tearing of eye on affected side

• TREATMENT: corticosteroids (decreases edema of nerve tissue) – Prednisone; and antiviral medications

• NURSING DX: altered body image; altered nutrition

Page 90: NEUROLOGIC DISORDERS

GUILLAIN BARRE SYNDROME• Autoimmune attack of the peripheral nerve myelin• RESULT: acute rapid demyelination of peripheral nerves and

some cranial nerves• PRODUCES:

– ***Ascending weakness with dyskinesia (inability to execute voluntary movements)

– Weaknss starts in legs and progresses upward for 1 month– ***Hyporeflexia– Paresthesias (numbness and pain)– MAXIMUM WEAKNESS:

• neuromuscular respiratory failure and • bulbar muscle weakness (demylelination of glossopharyngeal and vagus

nerves leads to inability to swallow or clear secretions)

Page 91: NEUROLOGIC DISORDERS

S & S CONTINUED

• VAGUS NERVE DEMYELINATION:– Leads to autonomic dysfunction– Manifested by instability of cardiovascular system– S & S: tachycardia, bradycardia, hypertension,

orthostatic hypotension

• NO COGNITIVE DYSFUNCTION

Page 92: NEUROLOGIC DISORDERS

SYMPTOMS CONTINUED

• PRECIPITATING EVENT: respiratory or GI infection, vaccination, surgery, pregnancy

• DURATION OF SYMPTOMS: may take up to two years to recover; some symptoms are permanent due to damage to nerves

Page 93: NEUROLOGIC DISORDERS

TREATMENT

• MEDICAL EMERGENCY: ICU• Rapid progression• Neuromuscular respiratory failure• May need mechanical ventilation• suctioning• Prevention of complications of immobility

Page 94: NEUROLOGIC DISORDERS

FOR CARDIOVASCULAR RISKS

• EKG• beta blocking agents for tachycardia and

hypertension• IV fluid for hypotension

Page 95: NEUROLOGIC DISORDERS

NURSING DIAGNOSIS